TRAF1/C5, eNOS, C1q, but not STAT4 and PTPN22 gene polymorphisms are associated with genetic susceptibility to systemic lupus erythematosus in Turkey

Human Immunology

Volumn 72, Issue 12, 2011, Pages 1210-1213

  Zervou, Maria I ^a   Vazgiourakis, Vassilios M ^a   Yilmaz, Neslihan ^b   Kontaki, Elena ^a   Trouw, Leendert A ^c   Toes, Rene E ^c   Bicakcigil, Muge ^b   Boumpas, Dimitrios T ^a,d,e   Yavuz, Sule ^b   Goulielmos, George N ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b MARMARA UNIVERSITY   (Turkey)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^e INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

Author keywords

Association study; Gene polymorphisms; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT COMPONENT C1Q; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; STAT4 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TURKEY (REPUBLIC); VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; CASE-CONTROL STUDIES; COHORT STUDIES; COMPLEMENT C1Q; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; RISK FACTORS; STAT4 TRANSCRIPTION FACTOR; TNF RECEPTOR-ASSOCIATED FACTOR 1; TURKEY;

EID: 81955167500     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.09.003     Document Type: Article

References (23)

1. Alarcón-Segovia D., Alarcón-Riquelme M.E., Cardiel M.H., Caeiro F., Massardo L., Villa A.R., et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005, 52:1138-1147.
2. Martens H.A., Nolte I.M., van der Steege G., Schipper M., Kallenberg C.G., Te Meerman G.J., et al. An extensive screen of the HLA region reveals an independent association of HLA class I and class II with susceptibility for systemic lupus erythematosus. Scand J Rheumatol 2009, 38:256-262.
3. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet 2004, 75:330-337.
4. Harley J.B., Alarcon-Riquelme M.E., Criswell L.A., Jacob C.O., Kimberly R.P., Moser K.L., et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008, 40:204-210.
5. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977-986.
6. Tan E.M., Cohen A.D., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
7. Vazgiourakis V., Sidiropoulos P., Bertsias G., Raptopoulou A., Koutsounaki E., Fragouli E., et al. Association of the nitric oxide synthase gene (eNOS) polymorphism with increased risk for rheumatoid arthritis-but not for systemic lupus erythematosus in population of Crete, a southern-eastern European Greek island. Lupus 2007, 16:867-874.
8. Zervou M.I., Sidiropoulos P., Petraki E., Vazgiourakis V., Krasoudaki E., Raptopoulou A., et al. Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population. Hum Immunol 2008, 69:567-571.
9. Eliopoulos E., Zervou M.I., Andreou A., Dimopoulou K., Voloudakis G., Cosmidis N., et al. Association of the PTPN22 R620W polymorphism with increased risk for SLE in the genetic homogeneous population of Crete. Lupus 2011, 10:501-506.
10. Gauderman W.J., Morrison J.M. Quanto. 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. 2006 http://hydra.usc.edu/gxe.
11. Kurreeman F.A., Padyukov L., Marques R.B., Schrodi S.J., Seddighzadeh M., Stoeken-Rijsbergen G., et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 2007, 4:e278.
12. Nishimoto K., Kochi Y., Ikari K., Yamamoto K., Suzuki A., Shimane K., et al. Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese. Ann Rheum Dis 2010, 69:368-373.
13. Palomino-Morales R.J., Rojas-Villarraga A., González C.I., Ramírez G., Anaya J.-M., Martín J. STAT4 but not TRAF1/C5 variants influence the risk of developing rheumatoid arthritis and systemic lupus erythematosus in Colombians. Influence of STAT4 variants in RA and SLE. Genes Immun 2008, 9:379-382.
14. Kurreeman F.A., Rocha D., Houwing-Duistermaat J., et al. Replication of the tumor necrosis factor receptor-associated factor 1/complement component 5 region as a susceptibility locus for rheumatoid arthritis in a European family-based study. Arthritis Rheum 2008, 58:2670-2674.
15. Martens H.A., Zuurman M.W., de Lange A.H., Nolte I.M., van der Steege G., Navis G.J., et al. Analysis of C1q polymorphisms suggests association with systemic lupus erythematosus, serum C1q and CH50 levels and disease severity. Ann Rheum Dis 2009, 68:715-720.
16. Trouw L.A., Kurreeman F.A.S., Daha N., Bohringer S., Stoeken-Rijsbergen G., Houwing-Duistermaat J.J., et al. Genetic variants of C1q are a risk for rheumatoid arthritis. Ann Rheum Dis 2011, 70(Suppl 2):A17.
17. Abelson A.K., Delgado-Vega A.M., Kozyrev S.V., Sánchez E., Velázquez-Cruz R., Eriksson N., et al. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis 2009, 68:1746-1753.
18. Kariuki S.N., Kirou K.A., MacDermott E.J., Barillas-Arias L., Crow M.K., Niewold T.B. Cutting edge: Autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J Immunol 2009, 182:34-38.
19. Aksoy R., Duman T., Keskin O., Düzgün N. No association of PTPN22 R620 W gene polymorphism with rheumatic heart disease and systemic lupus erythematosus. Mol Biol Rep 2011, DOI 10.1007/s11033-011-0692-7.
20. Plant D., Flynn E., Mbarek H., Dieudé P., Cornelis F., Arlestig L., et al. Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers. Ann Rheum Dis 2010, 69:1548-1553.
21. Mori M., Yamada R., Kobayashi K., Kawaida R., Yamamoto K. Ethnic differences in allele frequency of autoimmune-disease-associated SNPs. J Hum Genet 2005, 50:264-266.
22. Gregersen P.K., Lee H.S., Batliwalla F., Begovich A.B. PTPN22: Setting thresholds for autoimmunity. Semin Immunol 2006, 18:214-223.
23. Pearce N., Foliaki S., Sporle A., Cunningham C. Genetics, race, ethnicity, and health. BMJ 2004, 328:1070-1072.